Data as of Apr 17
| +0.45 / +0.73%|
The 20 analysts offering 12-month price forecasts for St. Jude Medical Inc have a median target of 72.50, with a high estimate of 80.00 and a low estimate of 51.00. The median estimate represents a +16.02% increase from the last price of 62.49.
The current consensus among 25 polled investment analysts is to Buy stock in St. Jude Medical Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.